BCMA-CD19 CCAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-CD19 CCAR T cells, covering 2025-01-22 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases [Phase 1]